Host: |
Rabbit |
Applications: |
DB/ELISA/IHC/IP/WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-PGAP3 (1-50) is suitable for use in Dot Blot, ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Biotin |
Isotype: |
IgG |
Purification: |
Affinity Purified |
Concentration: |
0.50-0.75 µg/µl |
Dilution Range: |
WB: 1:500-1:1, 000DB: 1:50, 000ELISA: 1:50, 000IP: 1:150IHC: 1:50-1:150 |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
PGAP3 |
Gene ID: |
93210 |
Uniprot ID: |
PGAP3_HUMAN |
Immunogen Region: |
1-50 |
Immunogen: |
Synthetic peptide taken within amino acid region 1-50 on human PGAP3 protein. |
Tissue Specificity | Ubiquitously expressed, with highest levels in thyroid and placenta. |
Function | Involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins. Required for phospholipase A2 activity that removes an acyl-chain at the sn-2 position of GPI-anchors during the remodeling of GPI. |
Protein Name | Post-Gpi Attachment To Proteins Factor 3Cos16 HomologHcos16Gene Coamplified With Erbb2 ProteinPer1-Like Domain-Containing Protein 1 |
Cellular Localisation | Golgi Apparatus MembraneMulti-Pass Membrane ProteinEndoplasmic Reticulum MembraneMainly Localizes To Golgi Apparatus |
Alternative Antibody Names | Anti-Post-Gpi Attachment To Proteins Factor 3 antibodyAnti-Cos16 Homolog antibodyAnti-Hcos16 antibodyAnti-Gene Coamplified With Erbb2 Protein antibodyAnti-Per1-Like Domain-Containing Protein 1 antibodyAnti-PGAP3 antibodyAnti-CAB2 antibodyAnti-PERLD1 antibodyAnti-UNQ546 antibodyAnti-PRO1100 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance